scispace - formally typeset
Journal ArticleDOI

Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor.

TLDR
Continuous intracerebral infusion of NGF over a period of four weeks can partly reverse the cholinergic cell body atrophy and improve retention of a spatial memory task in behaviourally impaired aged rats.
Abstract
In aged rodents, impairments in learning and memory have been associated with an age-dependent decline in forebrain of cholinergic function, and recent evidence indicates that the cholinergic neurons in the nucleus basalis magnocellularis, the septal-diagonal band area and the striatum undergo age-dependent atrophy. Thus, as in Alzheimer-type dementia in man, degenerative changes in the forebrain cholinergic system may contribute to age-related cognitive impairments in rodents. The cause of these degenerative changes is not known. Recent studies have shown that the central cholinergic neurons in the septal-diagonal band area, nucleus basalis and striatum are sensitive to the neurotrophic protein nerve growth factor (NGF). In particular, intraventricular injections or infusions of NGF in young adult rats have been shown to prevent retrograde neuronal cell death and promote behavioural recovery after damage to the septo-hippocampal connections. It is so far not known, however, whether the atrophic cholinergic neurons in aged animals are responsive to NGF treatment. We report here that continuous intracerebral infusion of NGF over a period of four weeks can partly reverse the cholinergic cell body atrophy and improve retention of a spatial memory task in behaviourally impaired aged rats.

read more

Citations
More filters
Journal ArticleDOI

Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery.

TL;DR: Because AAV2-NGF did not directly engage the target cholinergic neurons, it cannot conclude that growth factor gene therapy is ineffective for AD, and upcoming clinical trials for AD will utilize real-time MRI guidance and convection-enhanced delivery to improve the targeting and spread of growth factors gene delivery.
Journal ArticleDOI

Neurotrophic factors and diseases of the nervous system.

TL;DR: Delivery of neurotrophic factors to dysfunctional neurons may be a useful therapeutic strategy for promoting neuronal recovery in a number of diseases, including varicella‐zoster virus infection.
Journal ArticleDOI

Identification and structure of the nerve growth factor binding site on TrkA.

TL;DR: This work has expressed the second Ig-like domain as a recombinant protein in E. coli and demonstrated that NGF binds to this domain with similar affinity to the native receptor, TrkA, and presented the three-dimensional structure of the TrkAIg(2) domain in a new crystal form, refined to 2.0 A resolution.
Journal ArticleDOI

Responses of basal forebrain cholinergic neurons to damage in the adult brain

TL;DR: The hypothesis is put forward that the severity of the pathology in highly plastic limbic cortical areas could be linked with their susceptibility to risk factors of Alzheimer's disease such as ageing, and genetic and environmental factors.
References
More filters
Journal ArticleDOI

Developments of a water-maze procedure for studying spatial learning in the rat

TL;DR: Developments of an open-field water-maze procedure in which rats learn to escape from opaque water onto a hidden platform are described, suggesting that they may lend themselves to a variety of behavioural investigations, including pharmacological work and studies of cerebral function.
Journal ArticleDOI

The Cholinergic Hypothesis of Geriatric Memory Dysfunction

TL;DR: Biochemical, electrophysiological, and pharmacological evidence supporting a role for cholinergic dysfunction in age-related memory disturbances is critically reviewed and an attempt has been made to identify pseudoissues, resolve certain controversies, and clarify misconceptions that have occurred in the literature.
Journal ArticleDOI

Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections

TL;DR: It is suggested that fimbrial transections resulted in retrograde degeneration of cholinergic septo-hippocampal neurons and that NGF treatment strongly attenuated this lesion-induced degeneration.
Journal ArticleDOI

Nerve growth factor treatment after brain injury prevents neuronal death

TL;DR: Cholinergic neuronal degeneration after axotomy has been proposed to be due to the loss of a retrogradely transported neurotrophic factor, possibly nerve growth factor (NGF), and NGF was continuously infused into the lateral ventricles of adult rats that had received bilateral lesions of all cholinergic axons projecting from the medial septum to the dorsal hippocampus.
Related Papers (5)